Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11503-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#11503-1-AP, RRID:AB_2262942
- Product name
- FRS2 antibody
- Antibody type
- Polyclonal
- Description
- FRS2 antibody (Cat. #11503-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1.
Transcriptomics and Transposon Mutagenesis Identify Multiple Mechanisms of Resistance to the FGFR Inhibitor AZD4547.
Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma.
High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma.
Mouron S, Manso L, Caleiras E, Rodriguez-Peralto JL, Rueda OM, Caldas C, Colomer R, Quintela-Fandino M, Bueno MJ
Breast cancer research : BCR 2021 Feb 12;23(1):21
Breast cancer research : BCR 2021 Feb 12;23(1):21
Transcriptomics and Transposon Mutagenesis Identify Multiple Mechanisms of Resistance to the FGFR Inhibitor AZD4547.
Kas SM, de Ruiter JR, Schipper K, Schut E, Bombardelli L, Wientjens E, Drenth AP, de Korte-Grimmerink R, Mahakena S, Phillips C, Smith PD, Klarenbeek S, van de Wetering K, Berns A, Wessels LFA, Jonkers J
Cancer research 2018 Oct 1;78(19):5668-5679
Cancer research 2018 Oct 1;78(19):5668-5679
Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma.
Zhang K, Chu K, Wu X, Gao H, Wang J, Yuan YC, Loera S, Ho K, Wang Y, Chow W, Un F, Chu P, Yen Y
Cancer research 2013 Feb 15;73(4):1298-307
Cancer research 2013 Feb 15;73(4):1298-307
High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma.
Wang X, Asmann YW, Erickson-Johnson MR, Oliveira JL, Zhang H, Moura RD, Lazar AJ, Lev D, Bill K, Lloyd RV, Yaszemski MJ, Maran A, Oliveira AM
Genes, chromosomes & cancer 2011 Nov;50(11):849-58
Genes, chromosomes & cancer 2011 Nov;50(11):849-58
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- MCF-7 cells were subjected to SDS PAGE followed by western blot with 11503-1-AP( FRS2 Antibody) at dilution of 1:1000
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The FRS2 antibody from Proteintech is a rabbit polyclonal antibody to a peptide of human FRS2. This antibody recognizes human,mouse,rat antigen. The FRS2 antibody has been validated for the following applications: ELISA, IHC, WB analysis.